RxDoctor Payments Data

Isaac Whitman, MD

Clinical Cardiac Electrophysiology · Philadelphia, PANPI 1902040843

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $51,725 of the $77,266 with a category attached, or 66.9%. Impulse Dynamics (USA) Inc. accounts for 77.4% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2024 at $28,932 and has fallen 81.4% since, to $5,381 in 2025.

$77,266in general payments, 2019–2025

Across 205 payments — averaging $376.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Impulse Dynamics (USA) Inc.$60K
  • Boston Scientific$11K
  • Biosense Webster, Inc.$4K
  • Medtronic$2K
  • Philips North America LLC$265
  • Abbott$258
  • plus $356 from 3 others
$39,067in research payments, 2019–2025

Across 22 payments — averaging $1775.78 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Impulse Dynamics (USA) Inc.$39K

What the payments were for

  • Consulting fees$7,0509%
  • Speaking & faculty fees$51,72567%
  • Travel & lodging$10,98314%
  • Food & beverage$7,50810%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$77,266 in reported general payments places this provider in the 80th percentile of 201 clinical cardiac electrophysiology providers in Pennsylvania.

See all clinical cardiac electrophysiology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$103,161
Medicare patients
303
Services billed
867

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban40$51,924
XareltoRivaroxaban14$11,722
Flecainide Acetate23$739
Metoprolol Succinate33$588

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →